000 01213 a2200349 4500
005 20250516022032.0
264 0 _c20110621
008 201106s 0 0 eng d
022 _a1878-5832
024 7 _a10.1016/j.drudis.2011.01.007
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKanwar, Jagat R
245 0 0 _aAntiangiogenic therapy using nanotechnological-based delivery system.
_h[electronic resource]
260 _bDrug discovery today
_cMar 2011
300 _a188-202 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAngiogenesis Inhibitors
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aDrug Delivery Systems
650 0 4 _aHumans
650 0 4 _aNanoparticles
650 0 4 _aNanotechnology
_xmethods
650 0 4 _aNeoplasms
_xblood supply
650 0 4 _aNeoplastic Stem Cells
650 0 4 _aRNA
_xadministration & dosage
700 1 _aMahidhara, Ganesh
700 1 _aKanwar, Rupinder K
773 0 _tDrug discovery today
_gvol. 16
_gno. 5-6
_gp. 188-202
856 4 0 _uhttps://doi.org/10.1016/j.drudis.2011.01.007
_zAvailable from publisher's website
999 _c20543222
_d20543222